Artemether/Lemefantrine is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Falciparum malaria, uncomplicated disease in geographic areas of known chloroquine resistance.
- Not approved for patients with severe or complicated P. falciparum malaria.
- Not approved for the prevention of malaria.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Vivax malaria: Limited efficacy observed in one Thai study: rapid parasite clearance observed with 4-dose regimen, relapse was common, suggesting minimal activity against the hypnozoite stage of P. vivax[4].
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: June 27, 2014
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Artemether/Lemefantrine
ID - 540604
A1 - Jenh,Alice ,PharmD
AU - Pham,Paul,PharmD
Y1 - 2014/06/27/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540604/all/Artemether_Lemefantrine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -